RJA
ZTS icon

Ross\Johnson & Associates’s Zoetis ZTS Stock Holding History

Ross\Johnson & Associates’s Portfolio ZTS Stock Details ZTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216 Buy
3
+1
+50% +$94 ﹤0.01% 223
2026
Q1 		$236 Hold
2
– – ﹤0.01% 163
2025
Q4 		$252 Hold
2
– – ﹤0.01% 225
2025
Q3 		$293 Hold
2
– – 0.01% 153
2025
Q2 		$312 Hold
2
– – 0.01% 141
2025
Q1 		$329 Buy
+2
New +$333 0.01% 280

Other funds holding ZTS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ross\Johnson & Associates's ZTS Position: Q2 2026 in Review

Ross\Johnson & Associates increased its Zoetis (ZTS) stake by 50% in Q2 2026, buying an estimated $94 and bringing the position to 3 shares worth $216. The position accounts for ﹤0.01% of the portfolio, ranked #223.

Ross\Johnson & Associates first reported a position in ZTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $329 in Q1 2025. 1,430 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Ross\Johnson & Associates held 3 shares of Zoetis worth $216 as of Q2 2026.
  • Ross\Johnson & Associates bought 1 Zoetis share in Q2 2026, an estimated $94.
  • Zoetis made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #223 holding.
  • Ross\Johnson & Associates first reported a position in Zoetis in Q1 2025 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's Zoetis position peaked at $329 in Q1 2025.
  • 1,430 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.